Evaluation of Hepatitis B and C Reactivation in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors. (2026). Mediterranean Journal of Hematology and Infectious Diseases, 18(1), e2026001. https://doi.org/10.4084/MJHID.2026.001